NCT01101958View on ClinicalTrials.gov

A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Emphysema
Interventions
DEVICE

Chartis System

The Chartis System provides a value that represents the quantification of the average resistance to airflow through collateral airways.

DEVICE

Endobronchial Valve (EBV) Treatment

The endobronchial valve is designed to induce target lobe volume reduction.

Trial Locations (2)

69126

University of Heidelberg, Heidelberg

Unknown

UMC Groningen, Groningen

All Listed Sponsors
lead

Pulmonx Corporation

INDUSTRY

NCT01101958 - A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) | Biotech Hunter | Biotech Hunter